Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
4
×
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
4
×
wisconsin blog main
wisconsin top stories
abbvie
biogen
cancer
cancer immunotherapy
cystic fibrosis
deals
eli lilly
medicare
novartis
president trump
What
bio
drug
4
×
roundup
acquisitions
alzheimer’s
biggest
ceo
prices
week
albert
annual
assessed
attention
biotech
bourla
build
buy
communities
companies
company
company’s
conference
crispr
daniel
debut
different
dyne’s
esmo
europe
fail
future
gene
germany
gilead
hosted
imports
increases
investment
latest
maker
Language
unknown
unset
Current search:
drug
×
biotech
×
" texas top stories "
×
pfizer
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More